Karmanos Cancer Institute Wins $1.3M Pentagon Grant to Remain in Prostate Cancer Clinical Trials Consortium

Detroit’s Barbara Ann Karmanos Cancer Institute has snared a four-year, $1.23 million grant renewal from the U.S. Department of Defense to keep its membership in the prestigious Prostate Cancer Clinical Trials Consortium (PCCTC) program.

Read more.